News | Cancer

News

Draft NICE guidance recommends ‘at-home’ pill for advance prostate cancer

The National institute of Health and Care Excellence says up to 40,000 people in England could benefit from relugolix (Orgovyx; Accord).…

Published: 22 July 2024

Feature

Medical drone deliveries: a viable option for the NHS?

In this episode of The PJ Pod, we speak to experts who are testing the feasibility of using drones to deliver NHS medicines.…

Published: 10 July 2024

Feature

How AI is transforming drug discovery

Pharmaceutical companies and start-ups are harnessing AI to improve speed and reduce costs at every stage of the drug discovery and development process.…

Published: 3 July 2024

News

Combination treatment before surgery improves melanoma survival rates, study results show

The 12-month event-free survival rate for patients with macroscopic stage III node-positive melanoma was 83.7% with the combination treatment, compared with 57.2% for adjuvant therapy alone.…

Published: 11 June 2024

News

Osimertinib treatment for advanced non-small cell lung cancer increases survival rates, study finds

Patients treated with osimertinib had an average of 39.1 months of progression-free survival, compared with 5.6 months in those given placebo.…

Published: 5 June 2024

Feature

BRUKINSA: a next-generation BTK inhibitor

Read more to learn how BRUKINSA could benefit your patients with CLL.…

Published: 4 June 2024

Promotional content

Opinion

Why we are helping patients with lung cancer symptoms self-refer for a chest X-ray

Pharmacies in Leeds are helping to diagnose lung cancer earlier by piloting a service that allows patients with red-flag symptoms to refer themselves to hospital for testing.…

Published: 8 May 2024

News

More than 60 community pharmacies access cancer red-flag symptom card scheme

Exclusive: The ‘Not normal for you?’ scheme enables pharmacists to identify patient behaviours that may signal cancer and refer patients for red-flag symptoms.…

Published: 16 April 2024

News